VivoSeq
Other

Prostate CA

0

Pipeline Programs↗

3

Active Trials↗

0

Companies Involved↗

Prostate CA is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

20/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

5

clinical trials

Completed1 · 20%
Terminated1 · 20%
Active, not recruiting1 · 20%
Not yet recruiting1 · 20%
Recruiting1 · 20%

Clinical Trials

Trial Activity

Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
Completed·—·Phase 2·NCT01289067·13 enrolled
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
Terminated·NNorthwestern University·Phase 3·NCT00058188·53 enrolled
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
Active, not recruiting·—·Phase 2·NCT04519879·133 enrolled
A Study Assessing Whether Artificial Intelligence is Non-inferior to Radiologists in the Diagnosis of Clinically Significant Prostate Cancer.
Not yet recruiting·UUniversity College, London·Preclinical·NCT07647445·500 enrolled
PHASE II RANDOMIZED TRIAL OF 2- VS 5-FRACTION PROSTATE STEREOTACTIC ABLATIVE RADIOTHERAPY
Recruiting·BBritish Columbia Cancer Agency·Phase 2·NCT06835725·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)